HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Aspartylglucosaminuria — Clinical Guidelines

Overview

Aspartylglucosaminuria is a rare, recessively inherited lysosomal storage disorder characterized by the deficiency of aspartylglucosaminidase enzyme, leading to the accumulation of aspartylglucosamine and abnormal oligosaccharides in various tissues. 1 2

Diagnosis

Clinical Features: Mental retardation, facial dysmorphism, radiological abnormalities in skull and vertebrae, multivacuolated lymphocytes in peripheral blood smears. 2

Biochemical Tests: Absence of aspartylglucosaminidase activity in leucocytes and cultured fibroblasts. 2

Urinary Analysis: Demonstrates abnormal oligosacchariduria and excretion of aspartylglucosamine. 2

Serum Biomarkers: Elevated serum dolichol concentration may serve as a diagnostic marker, particularly useful given its exceptional elevation in this condition compared to others. 1

Management

No Specific Pharmacological Treatment: Currently, no specific drug therapy exists targeting the underlying enzyme deficiency. 1 2

Supportive Care: Focus on managing symptoms and complications, including developmental support, orthopedic interventions for skeletal abnormalities, and dermatological care for angiokeratomas. 2

Genetic Counseling: Essential for families with affected individuals due to its autosomal recessive inheritance pattern. 2

Special Populations

Pregnancy: No specific data provided regarding pregnancy outcomes or management in pregnant women with aspartylglucosaminuria. 1

Pediatrics: Early intervention for developmental delays and physical abnormalities is crucial. 2

Comorbidities: Management should consider coexisting conditions, though specific guidance is limited in the provided abstracts. 2

Key Recommendations

Utilize serum dolichol concentration as a potential diagnostic marker for aspartylglucosaminuria, given its exceptional elevation in this condition. (Evidence: Moderate) 1

Conduct comprehensive biochemical testing including leucocyte and fibroblast enzyme assays and urinary oligosaccharide analysis for definitive diagnosis. (Evidence: Moderate) 2

Implement supportive care strategies tailored to address developmental, orthopedic, and dermatological issues commonly encountered. (Evidence: Expert opinion) 2

References

1 Humaloja K, Roine RP, Salmela K, Halmesmäki E, Jokelainen K, Salaspuro M. Serum dolichols in different clinical conditions. Scandinavian journal of clinical and laboratory investigation 1991. link 2 Gehler J, Sewell AC, Becker C, Hartmann J, Spranger J. Clinical and biochemical delineation of aspartyl-glycosaminuria as observed in two members of an Italian family. Helvetica paediatrica acta 1981. link

Aspartylglucosaminuria